BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30055781)

  • 1. Combination Ipsilateral Lobar and Segmental Radioembolization Using Glass Yttrium-90 Microspheres for Treatment of Multifocal Hepatic Malignancies.
    Arslan B; Padela MT; Madassery S; Masrani A; Tasse J; Supanich M; Ahmed O
    J Vasc Interv Radiol; 2018 Aug; 29(8):1110-1116. PubMed ID: 30055781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres.
    Li MD; Chu KF; DePietro A; Wu V; Wehrenberg-Klee E; Zurkiya O; Liu RW; Ganguli S
    J Vasc Interv Radiol; 2019 Mar; 30(3):314-319. PubMed ID: 30819470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Radioembolization in the Setting of Angiographically Apparent Arterioportal Shunting.
    Thornton LM; Geller BS; Pepin EW; Shah JL; Kapp M; Toskich BB
    J Vasc Interv Radiol; 2018 Nov; 29(11):1511-1518. PubMed ID: 30293727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Boosted Radioembolization for Hepatocellular Carcinoma Larger than 5 cm.
    Kim HC; Kim YJ; Lee JH; Suh KS; Chung JW
    J Vasc Interv Radiol; 2019 Jan; 30(1):1-8. PubMed ID: 30293734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
    Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
    J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres.
    Hamoui N; Minocha J; Memon K; Sato K; Ryu R; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2013 Nov; 24(11):1743-5. PubMed ID: 24160828
    [No Abstract]   [Full Text] [Related]  

  • 9. Yttrium-90 Radioembolization with Resin Microspheres without Routine Embolization of the Gastroduodenal Artery.
    Ward TJ; Louie JD; Sze DY
    J Vasc Interv Radiol; 2017 Feb; 28(2):246-253. PubMed ID: 27884683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient single-session yttrium-90 glass microsphere radioembolization.
    Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary?
    McCann JW; Larkin AM; Martino LJ; Eschelman DJ; Gonsalves CF; Brown DB
    J Vasc Interv Radiol; 2012 May; 23(5):661-7. PubMed ID: 22440592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
    Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
    J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases.
    Dhingra S; Schwartz M; Kim E; Mabel Ko H; Ward SC; Fiel MI; Thung SN
    Semin Liver Dis; 2014 Nov; 34(4):465-8. PubMed ID: 25369308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres.
    Biederman DM; Titano JJ; Tabori NE; Pierobon ES; Alshebeeb K; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Nowakowski FS; Kim E
    J Vasc Interv Radiol; 2016 Jun; 27(6):812-821.e2. PubMed ID: 27062356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric injury from (90)Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?
    Gates VL; Hickey R; Marshall K; Williams M; Salzig K; Lewandowski RJ; Salem R
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2038-44. PubMed ID: 26194715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma.
    Allimant C; Kafrouni M; Delicque J; Ilonca D; Cassinotto C; Assenat E; Ursic-Bedoya J; Pageaux GP; Mariano-Goulart D; Aho S; Guiu B
    J Vasc Interv Radiol; 2018 Dec; 29(12):1662-1670.e4. PubMed ID: 30217745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioembolization with Yttrium-90 Microspheres for the Treatment of Liver Metastases of Pancreatic Adenocarcinoma: A Multicenter Analysis.
    Kim AY; Frantz S; Brower J; Akhter N
    J Vasc Interv Radiol; 2019 Mar; 30(3):298-304.e2. PubMed ID: 30819469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experience.
    Memon K; Kuzel TM; Vouche M; Atassi R; Lewandowski RJ; Salem R
    Melanoma Res; 2014 Jun; 24(3):244-51. PubMed ID: 24638152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.
    Riaz A; Gates VL; Atassi B; Lewandowski RJ; Mulcahy MF; Ryu RK; Sato KT; Baker T; Kulik L; Gupta R; Abecassis M; Benson AB; Omary R; Millender L; Kennedy A; Salem R
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):163-71. PubMed ID: 20421150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.